Catalyst
Slingshot members are tracking this event:
Phase 1 biomarker data of Sage Therapeutics' (SAGE) SAGE-718 in Huntington's disease due July 2019
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 24, 2019
Occurred Source:
https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-announces-clinical-updates-and-progress-across
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sage-718, Huntington's Disease, Biomarker Data
